ANI Pharmaceuticals (NASDAQ: ANIP ) is a profitable, fast growing biopharmaceutical company with a focus on rare diseases and underserved patients. ANIP’s growth has accelerated by reinvesting profits from its rare disease, generic, and branded drug sales into theI am presently working on a concept, I call investigative investing. A labor intensive exercise that combines investigative experience with mass collaboration in order to identify grossly undervalued stocks that are sitting on significant price mov ...